BCL6 promotes the progression of high-grade serous ovarian cancer cells by inhibiting PLAAT4
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.B-cell lymphoma 6 (BCL6) drives high-grade serous ovarian cancer (HGSOC) progression by downregulating PLAAT4, activating the PI3K/AKT pathway. Targeting this BCL6-PLAAT4-AKT axis offers a potential HGSOC therapeutic strategy.
Area Of Science
- Oncology
- Molecular Biology
- Cancer Research
Background
- B-cell lymphoma 6 (BCL6) is recognized as a cancer driver, but its role in high-grade serous ovarian cancer (HGSOC) progression is not fully understood.
- Investigating the molecular mechanisms of BCL6 in HGSOC is crucial for developing targeted therapies.
Purpose Of The Study
- To elucidate the molecular mechanisms by which BCL6 influences HGSOC progression.
- To identify downstream targets and pathways regulated by BCL6 in HGSOC.
Main Methods
- Immunohistochemical staining for BCL6 and PLAAT4 expression in HGSOC and normal tissues.
- Cleavage under targets and tagmentation (CUT&Tag) coupled with RNA sequencing (RNA-seq) to identify BCL6 regulatory mechanisms.
- In vitro and in vivo assays (wound healing, plate cloning, EdU, transwell, tumor models) to assess cell proliferation, invasion, and migration.
Main Results
- BCL6 expression is significantly elevated in HGSOC tissues, while PLAAT4 expression is reduced, correlating with poor patient prognosis.
- BCL6 promotes HGSOC cell proliferation, invasion, and migration in vitro and in vivo.
- BCL6 downregulates PLAAT4, leading to the activation of the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway.
Conclusions
- The BCL6-PLAAT4-AKT axis is a critical regulator of HGSOC progression.
- Targeting the BCL6-PLAAT4-AKT pathway presents a promising therapeutic strategy for HGSOC.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...